CNY 35.85
(0.87%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 2.89 Billion CNY | 9.85% |
2022 | 1.84 Billion CNY | 9.11% |
2021 | 1.68 Billion CNY | -16.0% |
2020 | 2 Billion CNY | 136.46% |
2019 | 849.88 Million CNY | 9.49% |
2018 | 776.19 Million CNY | 13.65% |
2017 | 682.97 Million CNY | 26.33% |
2016 | 540.64 Million CNY | 44.02% |
2015 | 375.4 Million CNY | 31.78% |
2014 | 284.86 Million CNY | 12.77% |
2013 | 252.6 Million CNY | -3.05% |
2012 | 260.55 Million CNY | 19.25% |
2011 | 218.49 Million CNY | 27.74% |
2010 | 171.05 Million CNY | 50.17% |
2009 | 113.9 Million CNY | 51.93% |
2008 | 74.97 Million CNY | 48.53% |
2007 | 50.47 Million CNY | 21.76% |
2006 | 41.45 Million CNY | 9.83% |
2005 | 37.74 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 410.86 Million CNY | -28.01% |
2024 Q1 | 570.72 Million CNY | 180.88% |
2024 Q3 | 296.22 Million CNY | -27.9% |
2023 Q4 | 203.19 Million CNY | -75.0% |
2023 Q2 | 932.33 Million CNY | 7.76% |
2023 FY | 2.02 Billion CNY | 9.85% |
2023 Q1 | 865.19 Million CNY | 53.21% |
2023 Q3 | 812.74 Million CNY | -12.83% |
2022 Q1 | 545.42 Million CNY | 256.14% |
2022 Q4 | 564.69 Million CNY | 59.55% |
2022 FY | 1.84 Billion CNY | 9.11% |
2022 Q3 | 353.92 Million CNY | -6.31% |
2022 Q2 | 377.75 Million CNY | -30.74% |
2021 Q1 | 526.02 Million CNY | 126.34% |
2021 FY | 1.68 Billion CNY | -16.0% |
2021 Q2 | 604.76 Million CNY | 14.97% |
2021 Q3 | 404.11 Million CNY | -33.18% |
2021 Q4 | 153.14 Million CNY | -62.1% |
2020 Q3 | 450.2 Million CNY | -49.17% |
2020 Q4 | 232.4 Million CNY | -48.38% |
2020 FY | 2 Billion CNY | 136.46% |
2020 Q2 | 885.69 Million CNY | 100.67% |
2020 Q1 | 441.36 Million CNY | 1527.68% |
2019 FY | 849.88 Million CNY | 9.49% |
2019 Q1 | 281.67 Million CNY | 915.09% |
2019 Q2 | 337.76 Million CNY | 19.91% |
2019 Q4 | 27.11 Million CNY | -86.66% |
2019 Q3 | 203.32 Million CNY | -39.8% |
2018 Q1 | 254.02 Million CNY | 437.62% |
2018 Q3 | 187.88 Million CNY | -38.71% |
2018 Q4 | 27.74 Million CNY | -85.23% |
2018 Q2 | 306.54 Million CNY | 20.67% |
2018 FY | 776.19 Million CNY | 13.65% |
2017 Q3 | 171.43 Million CNY | -31.33% |
2017 FY | 682.97 Million CNY | 26.33% |
2017 Q1 | 214.63 Million CNY | 185.42% |
2017 Q2 | 249.65 Million CNY | 16.32% |
2017 Q4 | 47.24 Million CNY | -72.44% |
2016 Q1 | 162.05 Million CNY | 386.41% |
2016 FY | 540.64 Million CNY | 44.02% |
2016 Q2 | 193.49 Million CNY | 19.4% |
2016 Q4 | 75.19 Million CNY | -31.57% |
2016 Q3 | 109.89 Million CNY | -43.2% |
2015 Q3 | 83.61 Million CNY | -40.52% |
2015 Q4 | 33.31 Million CNY | -60.15% |
2015 FY | 375.4 Million CNY | 31.78% |
2015 Q1 | 117.9 Million CNY | 659.66% |
2015 Q2 | 140.56 Million CNY | 19.22% |
2014 Q2 | 103.13 Million CNY | 7.08% |
2014 Q1 | 96.31 Million CNY | 208.12% |
2014 Q4 | 15.52 Million CNY | -77.79% |
2014 FY | 284.86 Million CNY | 12.77% |
2014 Q3 | 69.89 Million CNY | -32.23% |
2013 Q3 | 56.76 Million CNY | -34.96% |
2013 Q4 | 31.25 Million CNY | -44.93% |
2013 FY | 252.6 Million CNY | -3.05% |
2013 Q1 | 77.3 Million CNY | 31.87% |
2013 Q2 | 87.27 Million CNY | 12.9% |
2012 FY | 260.55 Million CNY | 19.25% |
2012 Q4 | 58.61 Million CNY | 3.79% |
2012 Q1 | 71.34 Million CNY | 21.51% |
2012 Q3 | 56.47 Million CNY | -23.79% |
2012 Q2 | 74.11 Million CNY | 3.88% |
2011 Q4 | 58.71 Million CNY | 102.84% |
2011 FY | 218.49 Million CNY | 27.74% |
2011 Q3 | 28.94 Million CNY | -56.44% |
2011 Q2 | 66.45 Million CNY | 3.23% |
2011 Q1 | 64.37 Million CNY | 30.62% |
2010 Q3 | 35.45 Million CNY | -22.92% |
2010 Q4 | 49.28 Million CNY | 39.01% |
2010 Q2 | 45.99 Million CNY | 14.09% |
2010 Q1 | 40.31 Million CNY | 47.79% |
2010 FY | 171.05 Million CNY | 50.17% |
2009 Q3 | 32.59 Million CNY | 11.14% |
2009 Q4 | 27.27 Million CNY | -16.3% |
2009 Q1 | 24.7 Million CNY | 45.96% |
2009 FY | 113.9 Million CNY | 51.93% |
2009 Q2 | 29.32 Million CNY | 18.71% |
2008 Q2 | 23.4 Million CNY | 53.12% |
2008 Q4 | 16.92 Million CNY | -12.51% |
2008 Q3 | 19.34 Million CNY | -17.36% |
2008 FY | 74.97 Million CNY | 48.53% |
2008 Q1 | 15.28 Million CNY | 50.24% |
2007 Q2 | 12.82 Million CNY | 32.86% |
2007 Q4 | 10.17 Million CNY | -42.92% |
2007 FY | 50.47 Million CNY | 21.76% |
2007 Q1 | 9.64 Million CNY | 0.0% |
2007 Q3 | 17.82 Million CNY | 39.05% |
2006 FY | 41.45 Million CNY | 9.83% |
2005 FY | 37.74 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Shenzhen Salubris Pharmaceuticals Co., Ltd. | 655.97 Million CNY | -341.098% |
Blue Sail Medical Co.,Ltd. | -604.84 Million CNY | 578.385% |
Andon Health Co., Ltd. | 1.61 Billion CNY | -79.331% |
Allmed Medical Products Co., Ltd | 180 Million CNY | -1507.473% |
Improve Medical Instruments Co., Ltd. | -40.81 Million CNY | 7189.57% |
Tofflon Science and Technology Group Co., Ltd. | 702.77 Million CNY | -311.722% |
Truking Technology Limited | 327.02 Million CNY | -784.784% |
Jiangxi Sanxin Medtec Co.,Ltd. | 257.64 Million CNY | -1023.074% |
Shenyang Xingqi Pharmaceutical Co.,Ltd | 276.51 Million CNY | -946.397% |
Autek China Inc. | 855.67 Million CNY | -238.155% |
Intco Medical Technology Co., Ltd. | 438.99 Million CNY | -559.125% |
Jiangsu Apon Medical Technology Co., Ltd. | 13.96 Million CNY | -20617.4% |
Winner Medical Co., Ltd. | 817.96 Million CNY | -253.741% |
Imeik Technology Development Co.,Ltd. | 2.15 Billion CNY | -34.069% |
Zhonghong Pulin Medical Products Co., Ltd. | -136.87 Million CNY | 2213.998% |
Caina Technology Co., Ltd. | 129.49 Million CNY | -2134.429% |